LBF20307PG39: Difference between revisions

Revision as of 11:22, 18 December 2008

Upper classes: LB LBF

15-epi-prostaglandin A2

Structural Information
	(5Z, 13E) - (8R,12S,15R) -15-hydroxy-9-oxoprost-5,10,13-trienoic acid
	15-epi-prostaglandin A2

Formula	C20H30O4
Exact Mass	334.21440944799997
Average Mass	334.4498
SMILES	`C(CC[C@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)C=CC(=O)1)CC`
Physicochemical Information












Spectral Information
Mass Spectra
UV Spectra
IR Spectra	n^fⁱ^l^m_m_a_x1350 and 970cm^-¹ Weinheimer_AJ et al.
NMR Spectra	¹H-NMRdppm5.41, 5.58. Weinheimer_AJ et al.
Other Spectra
Chromatograms

Reported Metabolites, References

Biospecies	ID	Compound Name	Reference	Comment
n.a.	LBF20307PG39	See above.	Weinheimer_AJ et al. 1969

@@ Line 5: / Line 5: @@
 |LipidMaps=LMFA03010092
 |SysName= (5Z, 13E) - (8R,12S,15R) -15-hydroxy-9-oxoprost-5,10,13-trienoic acid
-|Common Name=&&15-epi-prostaglandin A_2[[Reference:Weinheimer_AJ:Spraggins_RL:,Tetrahedron Lett.,1969,59,5185|{{RelationTable/GetFirstAuthor|Reference:Weinheimer_AJ:Spraggins_RL:,Tetrahedron Lett.,1969,59,5185}}]]&&
+|Common Name=&&15-epi-prostaglandin A2&&
 |IR Spectra=<FONT FACE="Symbol">n</FONT><SUP><FONT SIZE=-1>f</FONT></SUP><SUP><FONT SIZE=-1>i</FONT></SUP><SUP><FONT SIZE=-1>l</FONT></SUP><SUP><FONT SIZE=-1>m</FONT></SUP><SUB><FONT SIZE=-1>m</FONT></SUB><SUB><FONT SIZE=-1>a</FONT></SUB><SUB><FONT SIZE=-1>x</FONT></SUB>1350 and 970cm<SUP><FONT SIZE=-1>-</FONT></SUP><SUP><FONT SIZE=-1>1</FONT></SUP>[[Reference:Weinheimer_AJ:Spraggins_RL:,Tetrahedron Lett.,1969,59,5185|{{RelationTable/GetFirstAuthor|Reference:Weinheimer_AJ:Spraggins_RL:,Tetrahedron Lett.,1969,59,5185}}]]
 |NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H-NMR<FONT FACE="Symbol">d</FONT>ppm5.41, 5.58.[[Reference:Weinheimer_AJ:Spraggins_RL:,Tetrahedron Lett.,1969,59,5185|{{RelationTable/GetFirstAuthor|Reference:Weinheimer_AJ:Spraggins_RL:,Tetrahedron Lett.,1969,59,5185}}]]
 }}